Special Issue "Venom and Toxin as Targeted Therapy"
A special issue of Toxins (ISSN 2072-6651).
Deadline for manuscript submissions: closed (28 February 2019) | Viewed by 75493
A printed edition of this Special Issue is available here.
Interests: protease biochemistry; toxins; anti-cancer drug discovery; antibody therapy; venom-based peptides; prognostic and diagnostic biomarkers; proteomics
Special Issues, Collections and Topics in MDPI journals
Special Issue in Biology: Proteases—From Basic Structure to Function to Drug Design as Targeted Therapy
Special Issue in Biomolecules: Potential Mechanism of Natural-Based Biomolecules for Disease Treatment
Special Issue in Molecules: Recent Advances in Natural Drug Discovery and Development – Is It a New Wave of Medicine?
Special Issue in Biology: Recent Prototype Drug Development: Insights in Protein Science and Enzymology for Precision Medicine
Special Issue in Vaccines: Recent Discoveries and Developments in RNA and DNA Vaccines
Targeted therapy describes taking specific medications for treatment of particular diseases, such as cancer, diabetes, heart disease, etc. One of the most exciting recent developments in targeted therapies is the isolation of disease-specific molecules from natural resources, such as animal venoms and plant metabolites/toxins, to use as templates to design new drugs. As venom proteins/peptides and toxins naturally target mammalian receptors, they show high specificity and selectivity towards defined cell membrane ion channels and receptors.
The focus of this Special Issue of Toxins will be on the most recent advances related to the animal venom/plant toxin as medicinal therapy. Recent advances in venom/toxin targeted cancer therapy and immunotherapy will be addressed. The discussion on using novel disease-specific venom-based protein/peptide/toxin along with currently available FDA approved drugs as combinatorial treatment will also be encouraged in this context. Finally, an overview of some selected promising venom-based peptides/toxins potentially able to address the forthcoming challenges in this field will be included. Both research (in particular) and review articles proposing novelties or overviews, respectively, are welcome.
Prof. Dr. Hang Fai (Henry) Kwok
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Venom peptides
- Targeted therapy
- Combinatorial treatment
- Heart disease